# ZNF16 is a nucleolar-associated protein that regulates expression of rDNA and cancer-associated genes

## TL;DR

ZNF16 is a protein that regulates ribosomal RNA and cancer-related genes, affecting cell viability and multiple cellular pathways.

## Contribution

The study reveals ZNF16's role in regulating rDNA transcription and cancer-associated gene pathways.

## Key findings

- ZNF16 depletion reduces cell viability in cancer and non-cancer cell lines.
- ZNF16 localizes to the nucleolus and promotes rDNA transcription.
- ZNF16 influences pathways like extracellular matrix interaction and cancer.

## Abstract

ZNF16 (also known as HZF1 and KOX9) is a multi-C2H2 zinc finger protein first identified via its expression in human T-cells and shown to have a role in blood cell differentiation. ZNF16 was later shown to be ubiquitously expressed in a variety of fetal and adult tissues, suggesting a broader function. In this study, we confirm the ubiquitous expression of ZNF16 in a variety of cancer and non-cancer cell lines and show that ZNF16 depletion reduces cell viability in all cell lines tested. Furthermore, we show that ZNF16 localizes to the nucleolus in a transcription-dependent manner, interacts with the intergenic spacer region of the rDNA and promotes rDNA transcription. Additionally, RNA-sequencing experiments after ZNF16 depletion revealed that ZNF16 also has roles in a variety of pathways including extracellular matrix-receptor interaction, focal adhesions, cytokine-cytokine receptor interactions, human papillomavirus infection and cancer pathways. These findings are consistent with broader roles for ZNF16, including the regulation of nucleolar function, a process that is essential for all cells, and provide evidence at the cellular/molecular level of its role in the regulation of cancer-associated genes (e.g. NRAS, BIRC3, EGFR).

Summary: This study identifies new roles for the protein ZNF16 in the regulation of ribosomal RNA transcription and gene expression regulation for pathways involved in cancer.